Table 3 COX regression analysis of risk factors in patients with high-grade serous ovarian carcinoma

ETV5 expression (low- vs over-expression)

2.108(1.190–3.736)

0.011*

1.427(0.485–4.192)

0.518

Age (<55 vs ≥ 55)

0.534(0.322–0.885)

0.015*

0.713(0.379–1.340)

0.293

FIGO stage (I-IIvsIII-IV)

9.626(3.722–24.899)

≤0.001***

5.301(1.564–1.973)

0.007**

Recurrence (no vs yes)

2.542(1.178–5.482)

0.017*

2.670(1.140–6.253)

0.024*

Chemotherapy response (sensitive vs partial)

0.967(0.520–1.798)

0.915

Ascites (no vs yes)

1.192(0.562–2.527)

0.647